| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, ... Nature medicine 7 (5), 575-583, 2001 | 2152 | 2001 |
| Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization K Bajou, A Noël, RD Gerard, V Masson, N Brunner, C Holst-Hansen, ... Nature medicine 4 (8), 923-928, 1998 | 865 | 1998 |
| Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences V Tsatsaris, F Goffin, C Munaut, JF Brichant, MR Pignon, A Noel, ... The Journal of Clinical Endocrinology & Metabolism 88 (11), 5555-5563, 2003 | 630 | 2003 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 573 | 2018 |
| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy J Halkein, SP Tabruyn, M Ricke-Hoch, A Haghikia, M Scherr, ... The Journal of clinical investigation 123 (5), 2143-2154, 2013 | 554 | 2013 |
| Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomas C Munaut, A Noël, O Hougrand, JM Foidart, J Boniver, M Deprez International journal of cancer 106 (6), 848-855, 2003 | 426 | 2003 |
| Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization JM Rakic, V Lambert, L Devy, A Luttun, P Carmeliet, C Claes, L Nguyen, ... Investigative ophthalmology & visual science 44 (7), 3186-3193, 2003 | 418 | 2003 |
| The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies K Bajou, V Masson, RD Gerard, PM Schmitt, V Albert, M Praus, LR Lund, ... The Journal of cell biology 152 (4), 777-784, 2001 | 418 | 2001 |
| Targeting the tumor microenvironment for cancer therapy NE Sounni, A Noel Clinical chemistry 59 (1), 85-93, 2013 | 400 | 2013 |
| Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases MM Gueders, JM Foidart, A Noel, DD Cataldo European journal of pharmacology 533 (1-3), 133-144, 2006 | 386 | 2006 |
| Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice V Lambert, J Lecomte, S Hansen, S Blacher, MLA Gonzalez, I Struman, ... Nature protocols 8 (11), 2197-2211, 2013 | 378 | 2013 |
| In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy R Masson, O Lefebvre, A Noël, ME Fahime, MP Chenard, C Wendling, ... The Journal of cell biology 140 (6), 1535-1541, 1998 | 376 | 1998 |
| MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression NE Sounni, L Devy, A Hajitou, F Frankenne, C Munaut, C Gilles, ... The FASEB journal 16 (6), 555-564, 2002 | 372 | 2002 |
| The pro‐or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent L Devy, S Blacher, C Grignet-Debrus, K Bajou, V Masson, RD Gerard, ... The FASEB journal 16 (2), 147-154, 2002 | 348 | 2002 |
| Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8) A Gutiérrez-Fernández, M Inada, M Balbín, A Fueyo, AS Pitiot, A Astudillo, ... The FASEB journal: official publication of the Federation of American …, 2007 | 336 | 2007 |
| Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation EN Baramova, K Bajou, A Remacle, C L'hoir, HW Krell, UH Weidle, ... FEBS letters 405 (2), 157-162, 1997 | 336 | 1997 |
| Emerging roles of ADAM and ADAMTS metalloproteinases in cancer N Rocks, G Paulissen, M El Hour, F Quesada, C Crahay, M Gueders, ... Biochimie 90 (2), 369-379, 2008 | 326 | 2008 |
| MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells C Sabatel, L Malvaux, N Bovy, C Deroanne, V Lambert, MLA Gonzalez, ... PloS one 6 (2), e16979, 2011 | 322 | 2011 |
| Proteases, extracellular matrix, and cancer: a workshop of the path B study section YA DeClerck, AM Mercurio, MS Stack, HA Chapman, MM Zutter, ... The American journal of pathology 164 (4), 1131-1139, 2004 | 322 | 2004 |
| Matrix metalloproteinases at cancer tumor–host interface A Noël, M Jost, E Maquoi Seminars in cell & developmental biology 19 (1), 52-60, 2008 | 317 | 2008 |
